Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery.

Jason E. Ekert,Julianna Deakyne,Philippa Pribul Allen,Rebecca Terry,Christopher Schofield,Claire G. Jeong,Joanne Storey,Lisa Mohamet,Jo Francis,Anita A. Naidoo,Alejandro Amador,Jean-Louis Klein,Wendy C. Rowan

Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery.

2020

Jason E. Ekert
Julianna Deakyne
Philippa Pribul Allen
Rebecca Terry
Christopher Schofield
Claire G. Jeong
Joanne Storey
Lisa Mohamet
Jo Francis
Anita A. Naidoo
Alejandro Amador
Jean-Louis Klein
Wendy C. Rowan

The pharmaceutical industry is continuing to face high research and development (R&D) costs and low overall success rates of clinical compounds during drug development. There is an increasing deman...

Keywords:

3D bioprinting
Computational biology
Functional genomics
3D cell culture
Drug discovery
Biology
In vitro
Pharmaceutical industry
Biotechnology
Drug development
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations